ESIH:F:F-Ishares VI PLC - Ishares Msci Europe Health Care Sector Ucits ETF (EUR)

ETF | Others |

Last Closing

USD 6.887

Change

+0.08 (+1.12)%

Market Cap

USD 0.58B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.34 (-1.26%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.70 (-1.37%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.32 (-1.48%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.94 (-0.18%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.75 (-1.37%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

-0.01 (-0.01%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.60 (-1.55%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.20 (-1.31%)

USD 56.18B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.09 (-0.10%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.08 (-0.09%)

USD 51.63B

ETFs Containing ESIH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.04% 77% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.04% 75% C 65% D
Trailing 12 Months  
Capital Gain 8.07% 54% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.07% 52% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.14% 58% F 60% D-
Dividend Return 3.14% 56% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.12% 83% B 93% A
Risk Adjusted Return 61.25% 87% B+ 88% B+
Market Capitalization 0.58B 64% D 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike